Pricing

Log inSign up

Adverum Biotech

123 people · 5 jobs
‌

Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more

Industries

Biotechnology

Headquarters

Redwood City, United States

Employees

51-200

Links

Org chart

Laurent Fischer
President & CEO
Collapse
Kishor Peter Soparkar
COO
Linda Rubinstein
CFO
R. Andrew Ramelmeier
Chief Technology Officer
Romuald Corbau
Chief Scientific Officer
Dena House
SVP, Human Resources, Organizational Development & Learning
Bill Tan
SVP & Head, Global Clinical Operations
Aneta Ferguson
Svp, General Counsel
AR
Andy Ramelmeier
Chief Technology Officer
Peter Soparkar
Chief Operating Officer
Kathryn Ask
Senior Executive Assistant - C-suite & Board Of Directors
Star Seyedkazemi
Chief Development Officer

Board & advisors

JS
James Scopa
Director
ML
Mark Lupher
Director
Patrick Machado
Director
Dawn Svoronos
Director
Rabia Gurses Ozden
Director
Jeffrey Heier
Scientific Advisor
CN
C. David Nicholson
Director

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

171 followers

Regeneron

143 followers

Illumina

81 followers

Agilent Technologies

89 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

49 followers

Explore companies